| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/05/2004 | WO2004011488A2 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| 02/05/2004 | WO2004011485A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 02/05/2004 | WO2004011484A2 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
| 02/05/2004 | WO2004011476A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer |
| 02/05/2004 | WO2004011098A2 Golf shaft with adjustable stiffness and frequency |
| 02/05/2004 | WO2004011025A1 Plant cell wall loosening activity of group 2/3 allergens of grass pollen |
| 02/05/2004 | WO2004011018A2 Methods of identifying selective beta-1-adrenergic receptor antagonists |
| 02/05/2004 | WO2004010939A2 Methods of using non-human animal apoliprotein a-i protein |
| 02/05/2004 | WO2004010925A2 Mammalian genes involved in viral infection and tumor suppression |
| 02/05/2004 | WO2004010767A2 Application of aspen mads-box genes to alter reproduction and development in trees |
| 02/05/2004 | WO2003097871A3 Marker molecules associated with lung tumors |
| 02/05/2004 | WO2003097789A3 Farnesyl diphosphate synthase from pseudomonas aeruginosa |
| 02/05/2004 | WO2003097089A3 Attenuation of metapneumovirus |
| 02/05/2004 | WO2003093305A3 Teneurin c-terminal associated peptides (tcap) and uses thereof |
| 02/05/2004 | WO2003089624A3 Fc receptor homolog, reagents, and uses thereof |
| 02/05/2004 | WO2003087818A3 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 02/05/2004 | WO2003087289A3 Methods for the selection of compounds useful for the treatment of huntington’s disease |
| 02/05/2004 | WO2003087162A3 Neopeptides and methods useful for detection and treatment of cancer |
| 02/05/2004 | WO2003085086A9 Motif-grafted hybrid polypeptides and uses thereof |
| 02/05/2004 | WO2003084994A3 Use of biological photoreceptors as directly light-activated ion channels |
| 02/05/2004 | WO2003084989A3 La1 - the genome of a lactobacillus strain |
| 02/05/2004 | WO2003084560A3 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 02/05/2004 | WO2003082919A3 Ox40r binding agents |
| 02/05/2004 | WO2003082915A3 Xcrf polynucleotides and polypeptides and uses thereof |
| 02/05/2004 | WO2003079776A3 Identification of the flt1 gene required for angiogenesis in zebrafish, and uses thereof |
| 02/05/2004 | WO2003078464A3 Arrays of cytosolic accessory proteins immobilized on a surface and pertinent methods |
| 02/05/2004 | WO2003070282A3 Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue |
| 02/05/2004 | WO2003059944A3 Gb virus b based replicons and replicon enhanced cells |
| 02/05/2004 | WO2003055911A8 Cystine-knot fold protein |
| 02/05/2004 | WO2003052052A3 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| 02/05/2004 | WO2003051832A3 Histamine h2 receptor and uses |
| 02/05/2004 | WO2003048390A8 A process for the preparation of a non-toxic anthrax vaccine |
| 02/05/2004 | WO2003046137A3 Hiv envelope v3-ccr5 binding site immunogen |
| 02/05/2004 | WO2003042397A3 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 02/05/2004 | WO2003040304A3 Method of proliferation in neurogenic regions |
| 02/05/2004 | WO2003037172A3 Endothelial-cell binding peptides for diagnosis and therapy |
| 02/05/2004 | WO2003026418A3 Methods and compositions for regulation of cell death in plants |
| 02/05/2004 | WO2003006603A3 Triple polypeptide complexes |
| 02/05/2004 | WO2003004525A3 Isolation and purification of plasmodium falciparum merozoite protein-142 |
| 02/05/2004 | WO2002094378A3 Increased functional activity and/or expression of abc transporters protects against the loss of dopamine neurons associated with parkinson's disease |
| 02/05/2004 | WO2002072776A3 Cell culture system for synthesis of infectious hepatitis c virus |
| 02/05/2004 | WO2002061046A3 Novel nucleic acid and polypeptide molecules |
| 02/05/2004 | US20040025202 Nucleic acid molecules associated with oil in plants |
| 02/05/2004 | US20040025199 Comprises g-protein couple receptors for identifying modulators of g-protein activity and diagnosis and treatment of infections, nervous system, tumor, autoimmune and inflammatory disorders |
| 02/05/2004 | US20040025197 Transgenic animal |
| 02/05/2004 | US20040025195 Novel human cell surface protein with immunoglobulin folds, BGS-19 |
| 02/05/2004 | US20040025194 Beta chain-associated regulator of apoptosis |
| 02/05/2004 | US20040024725 Regulated apoptosis |
| 02/05/2004 | US20040024192 19 human secreted proteins |
| 02/05/2004 | US20040024188 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 02/05/2004 | US20040024187 Comprises receptor polypeptide associated with energy balance for diagnosis and treatment of arteriolosclerosis and inflammatory disorders |
| 02/05/2004 | US20040024186 Solubilizing, refolding and isolating preferential chemokines using low concentrations of chaotropic agents |
| 02/05/2004 | US20040024185 NF-AT-interacting protein NIP45 and methods of use therefor |
| 02/05/2004 | US20040024184 Regulation of human secretin receptor-like gpcr |
| 02/05/2004 | US20040024183 Comprises transport protein for diagnosis, prevention and treatment of nervous system, muscle, immunological and cell proliferative disorders; drug screening |
| 02/05/2004 | US20040024182 Comprises guanine nucleotide binding protein (GTP) for diagnosis, prevention and treatment of cell proliferative, autoimmune and inflammatory disorders |
| 02/05/2004 | US20040024181 Comprises polypeptide for treatment, diagnosis, and prevention of cancer, inflammation, nervous system disorders, learning and memory defects and sexual disorders |
| 02/05/2004 | US20040024179 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 02/05/2004 | US20040024178 Bacterial signal peptidase inhibitors and uses thereof |
| 02/05/2004 | US20040024068 Antimicrobial compounds |
| 02/05/2004 | US20040023949 Reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of- function comprising contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient |
| 02/05/2004 | US20040023915 Tocopherol associated protein and uses thereof |
| 02/05/2004 | US20040023911 Delivering a naked or isolated polynucleotide to the interior of a cell in a vertebrate, comprising the interstitial introduction of a naked polynucleotide into a tissue of the vertebrate where the polynucleotide is taken up by the cells |
| 02/05/2004 | US20040023910 Methods of inhibiting uterine leiomyoma proliferation and preventing formation of uterine leiomyomas, compounds and compositions that stimulate induction of the Cyr61 gene and compounds that increase Cyr61 activity. |
| 02/05/2004 | US20040023906 Antisense modulation of phosphotyrosyl phosphatase activator expression |
| 02/05/2004 | US20040023902 Delivery system contains a fusion protein having a target moiety and a nucleic acid binding moiety, and a nucleic acid sequence bound to the nucleic acid binding moiety of the fusion protein. The target moiety can be an antibody or a |
| 02/05/2004 | US20040023887 Peptide sequences capable of binding to insulin and/or insulin- like growth factor receptors with either agonist or antagonist activity and identified from various peptide libraries are disclosed. This invention also identifies at |
| 02/05/2004 | US20040023884 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 02/05/2004 | US20040023883 IGF-I and insulin variants are provided that selectively bind to IGFBP-1 or IGFBP-3. These agonist variants are useful, for example, to improve the half-lives of IGF-I and insulin, respectively. |
| 02/05/2004 | US20040023882 PTH derivatives resistant to skin proteases |
| 02/05/2004 | US20040023880 Methods of inducing formation of functional and organized lymphatic vessels |
| 02/05/2004 | US20040023876 Reagents which regulate human serotonin receptor precursor and reagents which bind to human serotonin receptor precursor gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited |
| 02/05/2004 | US20040023875 Insect inhibitory bacillus thuringiensis proteins, fusions, and methods of use therefor |
| 02/05/2004 | US20040023874 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/05/2004 | US20040023873 A novel protein, enkurin, that is preferentially expressed in sperm has been discovered. Enkurin binds to TRPCs including TRPC2-S, a protein encoded by TRPC2 that is not predicted to be a calcium channel subunit. The invention includes methods |
| 02/05/2004 | US20040023872 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage |
| 02/05/2004 | US20040023870 Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins |
| 02/05/2004 | US20040023868 Directed to compositions comprising nisin and sublancin in amounts that are effective to inhibit bacterial spore germination. Additionally, the present invention is directed towards methods of inhibiting bacterial spore germination for |
| 02/05/2004 | US20040023866 Isolated Bcl-2 domain-containing polypeptides from Mycobacterial species, including M. tuberculosis, M. avium, M. bovis, M. leprae and M. smegmatis, and from Streptomyces species, including S. coelicolor, as well as modifications of |
| 02/05/2004 | US20040023865 Polypeptides that contain at least one antigenic portion of a B. microti antigen and DNA sequences encoding such polypeptides. Antigenic epitopes of such antigens are also provided, together with pharmaceutical compositions and |
| 02/05/2004 | US20040023864 Novel activity in regulating angiogenesis. New variant Ryk proteins were constructed that were useful in modulating the capillary forming activity of endothelial cells. Variant Ryk proteins, may be employed as therpeutics in diseases such as |
| 02/05/2004 | US20040023862 Newly identified uses of BRS3 polypeptides and polynucleotides encoding such polypeptides, to their use in therapy of ischemia, of neurodegenerative diseases, of memory and attention disorders, and in identifying compounds which may be |
| 02/05/2004 | US20040023861 Isolated cysteinyl leukotriene receptor polypeptide comprising amino acid sequence of SEQ ID NO: 2 or variant thereof which is capable of binding a leukotriene; or fragment of (i) or (ii) which is capable of binding a leukotriene. |
| 02/05/2004 | US20040023860 Methods and compositions for inhibiting neoplastic cell growth |
| 02/05/2004 | US20040023859 New melanocortin receptor ligands are cyclic peptide analogs that preferably exhibit selectivity for the MC-4 and/or the MC-3 receptors relative to the other melanocortin receptors |
| 02/05/2004 | US20040023856 Purified DNA comprising a sequence encoding a B1k chain of laminin. Vector comprising a DNA sequence encoding a B1k protein. |
| 02/05/2004 | US20040023854 Adiponectin and uses thereof |
| 02/05/2004 | US20040023846 Protein conformational isomers, methods of making, methods for using, compositions comprising and products made therewith |
| 02/05/2004 | US20040023804 Plant derived antioxidants |
| 02/05/2004 | US20040023395 Transgenic tetraploid plants and methods of production |
| 02/05/2004 | US20040023389 Plasmid coding proteins associated with immune response for immunotherapeutic treatment of cancer; gene therapy; anticarcinogenic agents |
| 02/05/2004 | US20040023383 Antisense modulation of resistin expression |
| 02/05/2004 | US20040023380 Antisense modulation of G protein-coupled receptor 6 expression |
| 02/05/2004 | US20040023373 Novel mucosal vascular addressins |
| 02/05/2004 | US20040023372 Tubular nanostructures |
| 02/05/2004 | US20040023356 Comprise nucleotides equences coding polypeptide for use in diagnosis and treatment of bone, eye and peridontal disease |
| 02/05/2004 | US20040023343 Biosynthetic genes for spinosyn insecticide production |
| 02/05/2004 | US20040023338 Comprises genetically engineered interleukin 4 polypeptide for diagnosing and treating inflammatory, autoimmune, nervous system, cardiovascular, cancer and infectious diseases |
| 02/05/2004 | US20040023337 IL-13 mutein proteins, antibodies, compositions, methods and uses |
| 02/05/2004 | US20040023336 Mut-IL-18 or Mut-IL-18R proteins, antibodies, compositions, methods and uses |